Dix D, Cohen P, Kingsley S, Senkbeil J, Sexton K
Clin Chem. 1979 Jun;25(6):877-9.
We concurrently measured glycohemoglobin and performed 3-h oral (100 g) glucose tolerance tests on 69 ambulatory patients suspected of having abnormal carbohydrate metabolism. The patients were divided into two groups: (a) The 37 patients for whom the results were normal had plasma glucose concentrations of 0.70--1.15 milligram during fasting and 0.70--1.23 g/L 2 h after glucose ingestion. (b) Borderline diabetics exceeded one or both of these limits. The range of glycohemoglobin in the normal group was 3.0--4.7% of total hemoglobin. Of the 21 borderline diabetics, 11 had increased glycohemoglobin (4.8--8.0%). The difference in tolerance test results between borderline diabetics with and without increased glycohemoglobin was insufficient to predict the status of glycohemoglobin. We suggest a tentative definition for latent diabetes: increased glycohemoglobin in the presence of normal or borderline-abnormal glucose concentration in plasma collected during fasting.
我们对69例怀疑有碳水化合物代谢异常的门诊患者同时测定了糖化血红蛋白,并进行了3小时口服(100克)葡萄糖耐量试验。患者分为两组:(a)37例结果正常的患者,空腹时血浆葡萄糖浓度为0.70--1.15毫克,摄入葡萄糖后2小时为0.70--1.23克/升。(b)边缘性糖尿病患者超过了这些限度中的一项或两项。正常组糖化血红蛋白范围为总血红蛋白的3.0--4.7%。在21例边缘性糖尿病患者中,11例糖化血红蛋白升高(4.8--8.0%)。糖化血红蛋白升高和未升高的边缘性糖尿病患者的耐量试验结果差异不足以预测糖化血红蛋白状态。我们提出潜在糖尿病的初步定义:空腹采集的血浆葡萄糖浓度正常或临界异常时糖化血红蛋白升高。